Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 121 to 135 of 208 results for arthritis

  1. Synthetic cartilage implant insertion for first metatarsophalangeal joint osteoarthritis (hallux rigidus) (IPG727)

    Evidence-based recommendations on synthetic cartilage implant insertion for first metatarsophalangeal joint osteoarthritis (hallux rigidus). This involves replacing damaged cartilage with an artificial (synthetic) implant.

  2. NICE recommended that research should be carried out to determine the relationship between activity and prosthesis failure.

    guidance Total hip replacement and resurfacing arthroplasty for end-stage arthritis of the hip Number TA304 Date issued February 2014

  3. Cox-II inhibitors for the treatment of osteoarthritis and rheumatoid arthritis [ID388]

    Discontinued [GID-TAG372]

  4. Subcutaneous methotrexate:- What is the clinical and cost effectiveness of subcutaneous methotrexate compared with oral methotrexate for adults with early onset RA starting a new DMARD?

    Source guidance details Comes from guidance Rheumatoid arthritis in adults: management Number NG100 Date issued July

  5. Ultrasound in diagnosis:- What is the clinical and cost effectiveness of using ultrasound in addition to clinical assessment when there is uncertainty about the diagnosis in adults with suspected RA?

    Source guidance details Comes from guidance Rheumatoid arthritis in adults: management Number NG100 Date issued July

  6. FRAX and QFracture in adults with secondary causes of osteoporosis:- What is the utility of FRAX and QFracture in detecting risk of fragility fracture in adults with secondary causes of osteoporosis?

    in patients with causes of secondary osteoporosis other than rheumatoid arthritis and to establish whether their effect on fracture risk...

  7. Immune (idiopathic) thrombocytopenic purpura: rituximab (ESUOM35)

    Summary of the evidence on rituximab for immune (idiopathic) thrombocytopenic purpura in adults to inform local NHS planning and decision-making

  8. Ultrasound in monitoring:- What is the clinical and cost effectiveness of using ultrasound to monitor disease in adults with RA when clinical examination is inconclusive or inconsistent with other signs of disease activity?

    Source guidance details Comes from guidance Rheumatoid arthritis in adults: management Number NG100 Date issued July

  9. Home-testing devices for diagnosing obstructive sleep apnoea hypopnoea syndrome (DG62)

    Evidence-based recommendations on home-testing devices for diagnosing obstructive sleep apnoea hypopnoea syndrome